OKLAHOMA: Fatalities Linked to Meth Use Reported

Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.

OKLAHOMA: Fatalities Linked to Meth Use Reported

Associated Press (12.26.06) - Thursday, December 28, 2006

The US Drug Enforcement Agency reported recently that methamphetamine use "remains the principal drug of concern in the state of Oklahoma." That follows a state report that estimated substance abuse costs the state $3.21 billion-$4.38 billion per year, based on 2003 figures. Methamphetamine in particular has been cited for several recent deaths in the state. "We know that people who have substance abuse problems make more hospital visits and get referrals to child protective services," said Jennifer Glover, substance abuse services director for the state Department of Mental Health and Substance Abuse Services. Oklahoma has traced increased HIV, hepatitis C, and hepatitis B cases directly to methamphetamine use, she noted. "It's not only those who use intravenously, but it happens to non-injecting users because of the risky sexual behaviors associated with meth use."
061228
AD062516

Copyright © 2006 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.